@Article{Martz2021,
journal="Journal of Contemporary Brachytherapy",
issn="1689-832X",
volume="13",
number="5",
year="2021",
title="Brachytherapy for oligometastatic prostate cancer to the penis",
abstract="The origin of penile metastases is in 70% of cases from primary pelvic cancers (genitourinary and recto-sigmoid primary tumors). The prognosis is poor and it is often associated with synchronous bone metastases at the time of diagnosis.  We present the case of a 61-year-old patient who developed a penile induration 7 years after radical prostatectomy followed by adjuvant external beam radiation therapy for high-risk prostatic adenocarcinoma. Biopsies confirmed the metastatic localization and a detailed assessment failed to find any further remote lesions. Faced with this penile oligometastatic prostate cancer, we proposed an ablative treatment based on interstitial multi-catheter high-dose rate brachytherapy. At the six-month follow-up, clinical examination and 68Ga-PSMA-11-PET confirmed a complete response of the penile tumor without new lesion at a distance.",
author="Martz, Nicolas
and Benziane-Ouaritini, Nicolas
and Gautier, Mathieu
and Brenot-Rossi, Isabelle
and Montagne, Lucile
and Salem, Naji
and Bodokh, Yohan
and Hannoun-Levi, Jean-Michel",
pages="593--597",
doi="10.5114/jcb.2021.109754",
url="http://dx.doi.org/10.5114/jcb.2021.109754"
}